from Reuters: Health News http://ift.tt/2Buyanp
Tuesday, 28 November 2017
Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial
FRANKFURT (Reuters) - Germany's Merck KGaA suffered a setback in the development of key cancer immunotherapy Bavencio, which failed to prolong lives in gastric cancer patients when compared with standard chemotherapy.
from Reuters: Health News http://ift.tt/2Buyanp
from Reuters: Health News http://ift.tt/2Buyanp
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment